Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Mid-range Performer

5566.0000 -31.00 (-0.55%)

NSE Dec 24, 2025 15:31 PM

Volume: 41,257

Alkem Laboratories Ltd.

08 Nov 2023

5566.00

-0.55%

Alkem Labs (HOLD): Sizeable margin gains; tax guided to reduce raise to HOLD

Hold: Alkem Laboratories Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Q2 EBITDA/PAT outstripped consensus by 44%/54% on higher margins, strong US growth and low taxes

Number of FII/FPI investors increased from 551 to 589 in Sep 2025 qtr.